Monday, February 24, 2025
spot_img

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Conference call scheduled for 8:00 a.m. Eastern Time

WALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 20, 2025, at 8:00 a.m. Eastern Time to discuss financial results and provide a business update from the full year and fourth quarter of 2024.

To participate in the conference call, please dial (877) 346-6112 (domestic) or (848) 280-6350 (international) and ask to be joined into the Ardelyx call. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company’s website at www.ardelyx.com. The webcast will be archived and available for replay for 30 days following the call.

About Ardelyx
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

Powered by SlickText.com

Hot this week

4/2025・Trifork Group AG – Change to the Board of Directors

Company announcement no. 4 / 2025 Schindellegi, Switzerland –...

Sunlands Integrates DeepSeek AI Model, Ushering in a New Era for Adult Education

BEIJING, Feb. 24, 2025 (GLOBE NEWSWIRE) --...

Holding(s) in Company

TR-1: Standard form for notification of major holdings ...

Danske Bank share buy-back programme: transactions in week 8

  Company announcement no. 9 2025Danske BankBernstorffsgade 40DK-1577...

Alm. Brand A/S – Weekly report on share buybacks

Alm. Brand A/S share buy-back program Transactions during...

Topics

4/2025・Trifork Group AG – Change to the Board of Directors

Company announcement no. 4 / 2025 Schindellegi, Switzerland –...

Holding(s) in Company

TR-1: Standard form for notification of major holdings ...

Danske Bank share buy-back programme: transactions in week 8

  Company announcement no. 9 2025Danske BankBernstorffsgade 40DK-1577...

Alm. Brand A/S – Weekly report on share buybacks

Alm. Brand A/S share buy-back program Transactions during...

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq...

Man Group PLC : Form 8.3 – Spirent Communications plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY...
spot_img

Related Articles

Popular Categories

spot_img